Payers saw their Medicare Advantage margins revert back to pre-pandemic levels in 2021, yet those margins were still double those seen in other markets, according to a new analysis from the Kaiser Family Foundation. By the end of 2021, gross margins per enrollee had returned to pre-pandemic levels in the Medicare Advantage market, while gross […]
Eli Lilly has announced that it is reducing the list price of its insulin by 70% and capping out-of-pocket costs at $35 a month as part of its Insulin Value Program.
The WHO’s Global Strategy on Digital Health and the G20 Riyadh declaration aligned on issues including workforce development, says Taghreed Justinia, regional director for IT Services at King Saud bin Abdulaziz University for Health Sciences.
Medicare Advantage insurtech company Clover Health logged an $84 million loss in the fourth quarter of 2022, much less than the $187.2 million loss it sustained during the same quarter in 2021, according to the company’s earnings report.
Hospitals entered 2023 on more stable footing, following the worst financial year since the start of the COVID-19 pandemic. However, they still face a range of persistent challenges, including higher labor expenses, lower patient volumes and a fundamental shift in where patients access care services, according to Kaufman Hall’s latest Flash Report.
Much can be learned from donating UpToDate to middle- and low-income countries, including how access to evidence-based clinical guidance can reduce barriers anywhere, says Wolters Kluwer Health CMO Dr. Peter Bonis.
Medicare Advantage had fewer avoidable hospitalizations for ambulatory care−sensitive conditions (ACSCs) when compared to traditional Medicare, but were more likely to have observation stays and emergency department direct discharges for the same conditions, according to findings published in the Journal of the
The Centers for Medicare and Medicaid Services has released guidance for beneficiaries and providers on what to expect when the Public Health Emergency ends on Thursday, May 11.
Saudi Ministry of Health advisor for digital transformation Dr. Ahmed Balkhair explains how value-based healthcare helps improve the output of care and quality.
A new Optum report highlighting upcoming medications in the drug pipeline is meant as a heads-up for payers as they track developments with a couple of therapies for Alzheimer’s disease – lecanemab and donanemab.